Edition:
India

MiMedx Group Inc (MDXG.OQ)

MDXG.OQ on NASDAQ Stock Exchange Capital Market

12.25USD
2:29am IST
Change (% chg)

$0.60 (+5.15%)
Prev Close
$11.65
Open
$11.65
Day's High
$12.31
Day's Low
$11.65
Volume
471,351
Avg. Vol
668,761
52-wk High
$17.47
52-wk Low
$7.64

Select another date:

Thu, Nov 30 2017

BRIEF-MiMedx Says It Expects To Exceed Top End Of Q4 Revenue Guidance Of $88 Mln

* MIMEDX ANNOUNCES EXPECTATION TO EXCEED TOP END OF FOURTH QUARTER REVENUE GUIDANCE OF $88 MILLION

BRIEF-Mimedx provides update on its reimbursement coverage

* Mimedx Group Inc - ‍provided a reimbursement update in light of FDA final and draft guidance documents related to human tissue​

BRIEF-MiMedx Group sees FY 2017 revenue $320.6 million to $321.6 million

* MiMedx Group Inc - ‍reiterates Q4 and full year 2017 guidance​

BRIEF-MiMedx announces Q3 2017 results

* MiMedx announces record results for third quarter of 2017 and raises full year revenue guidance

BRIEF-Mimedx Group Inc preliminary Q3 revenue $84.6 million

* Announces third quarter revenues of $84.6 million exceeds guidance by more than 5 percent

BRIEF-MiMedx board authorizes $10 mln increase to share repurchase program

* MiMedx board of directors authorizes $10 million increase to the company's share repurchase program

BRIEF-MIMEDX GROUP REAFFIRMS REVENUE EXPECTATIONS FOR Q3

* DR. GLORIA MATTHEWS JOINS MIMEDX AS ITS SENIOR VICE PRESIDENT OF RESEARCH AND DEVELOPMENT

BRIEF-Court sets trial date for MiMedx patent infringement lawsuit

* Court sets the trial date for MiMedx patent infringement lawsuit against MTF, Medline and Liventa

BRIEF-MiMedx agrees to lawsuit settlement with terminated employee

* MiMedx agrees to lawsuit settlement with terminated employee

BRIEF-MiMedx provides information on its interaction with the SEC

* MiMedx provides information on its interaction with the SEC

Select another date: